Search

Search Constraints

You searched for: Author/Creator El Dakdouki, Yolla

Search Results

1. Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R‐Mini‐CYVE) regimen for patients with relapsed or refractory B‐cell non–Hodgkin's lymphoma not eligible for intensive chemotherapy. (4th February 2021)

2. Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. (March 2018)

3. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li‐Fraumeni syndrome) germline mutations. Issue 1 (9th November 2018)